Kineta: Funding, Investors & Team (Oct 2026)
Kineta is a biotech firm that is involved in the exploration and advancement of antiviral treatments and immune-modifying medications for the management of RNA viruses such as hepatitis C, influenza, West Nile virus, and the common cold.
Kineta has raised $13.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Oct 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kineta Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Kineta Funding Rounds
Kineta raised $10.0M in an undisclosed round announced in Jun 2021.
2.3 years later, an undisclosed round of $3.0M was announced in Oct 2023.
Kineta Founders and Leadership Team
Contact details for the Kineta team: 1 of 2 have an email address on file.
Start 14-day free trial →Kineta Funding Compared to Other Biotechnology Startups
Kineta's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kineta in Biotechnology and Seattle
Companies Similar to Kineta
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Kineta Funding FAQs
What does Kineta do?
Kineta is a biotech firm that is involved in the exploration and advancement of antiviral treatments and immune-modifying medications for the management of RNA viruses such as hepatitis C, influenza, West Nile virus, and the common cold.
How much funding has Kineta raised?
Kineta has raised $13.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in Oct 2023.
When did Kineta last raise funding?
Kineta's most recent funding round on record is an undisclosed round of $3.0M, announced in Oct 2023.
Who founded Kineta?
FundedIQ lists Charles Magness (Founder) at Kineta.
Who is the CEO of Kineta?
Shawn Iadonato is listed as CEO at Kineta.
Where is Kineta headquartered?
Kineta is based in Seattle, Washington, United States.
How many employees does Kineta have?
Kineta is in the 11-50 employee band.
How does Kineta's funding compare to other Biotechnology startups?
Kineta's latest round of $3.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kineta Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kineta is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.